Table 2 Mean weight loss (kg) between baseline and month 12 per participant, treatment group and country (using LOCF, and completers only)

From: A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial

 

CP

Mean

s.d.

SC

s.d.

N

 

P

 

Mean

  

Mean

  

Coefficient b

 

Australia

 LOCF

−6.21

6.53

120

−2.72

4.93

123

−3.49

<0.0001

 CCa

−7.75

6.48

78

−4.20

5.11

63

−3.55

0.001

United Kingdom

 LOCF

−4.91

5.10

91

−1.73

3.13

87

−3.18

<0.0001

 CCa

−7.52

5.28

27

−4.46

3.97

17

−3.06

0.047

Germany

 LOCF

−3.84

6.58

107

−2.31

4.35

131

−1.53

0.033

 CCa

−5.40

7.01

71

−2.71

5.00

88

−2.69

0.005

  1. Abbreviations: CP, commercial provider; LOCF, last-observation carried forward; SC, standard care.
  2. aComplete case.
  3. bCoefficient is the change in weight (kg) for CP compared with SC.
Back to article page